Your session is about to expire
β Back to Search
Celecoxib for Obsessive-Compulsive Disorder
Study Summary
This trial will help researchers understand if anti-inflammatory drugs can be effective in treating OCD when used in addition to traditional medications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 2 trial β’ 255 Patients β’ NCT01062113Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You cannot have an MRI or PET scan because you have metal implants.I am between 18 and 55 years old.My OCD symptoms persist despite current medication.My main diagnosis is Obsessive-Compulsive Disorder.My OCD symptoms persist despite taking psychiatric medication.My main diagnosis is Obsessive-Compulsive Disorder.I am between 18 and 55 years old.I am not taking any medications that could affect the study drug.I understand and can agree to the study's procedures and risks.You have mental health conditions that could make it risky for you to take part in the study or affect the study results (for example, thoughts of harming yourself).I started a new OCD treatment within the last 4 weeks.I am between 18 and 55 years old.My OCD symptoms persist despite current medication.
- Group 1: Celecoxib Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Celecoxib been endorsed by the FDA?
"The safety of Celecoxib has been assessed by Power personnel, and it was assigned a 2 on the 1-3 scale. This evaluation is based off Phase 2 trial findings which indicate there are some data supporting its safety but none verifying its efficacy."
Who would be the ideal candidates to participate in this medical experiment?
"This clinical trial seeks 21 individuals aged between 18 and 55, who suffer from obsessive-compulsive disorder. The key prerequisites for selection are to be within the specified age range and present a persistent case of OCD despite being medicated with psychiatric medication."
What is the cap on participant numbers for this trial?
"Affirmative. The information on clinicaltrials.gov indicates that this medical experiment is now seeking participants, with the initial posting taking place on April 1st 2021 and most recent update occuring on July 29th 2022. 21 patients need to be recruited from a single site for enrollment in this trial."
Does the protocol for this research exclude individuals who have surpassed their eightieth birthday?
"This clinical trial is recruiting volunteers aged 18 and above, but below the age of 55."
Are there any recruitment opportunities for this research endeavor at present?
"Correct. According to clinicaltrials.gov, this ongoing study is currently enrolling patients and was posted on April 1st 2021 with its most recent update being July 29th 2022. 21 individuals are needed from a single medical centre for the trial's completion."
What medical applications has Celecoxib been effective for?
"Celecoxib is a common form of pain relief, though its applications extend to primary dysmenorrhoea, rheumatoid arthritis, and ankylosing spondylitis."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger